Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.75 +0.02 (+0.23%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Net Income towards Common Stockholders (2025)

Drugs Made In America Acquisition's (DMAA) quarterly Net Income towards Common Stockholders came in at -$1.8 million in Q4 2025, down 222.71% on a QoQ basis from $1.5 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Net Income towards Common Stockholders (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 1 years of Net Income towards Common Stockholders data on file, last reported at -$1.8 million in Q4 2025.

  • Quarterly Net Income towards Common Stockholders changed N/A year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, up 805.2% from the prior year.
  • Net Income towards Common Stockholders retreated to -$1.8 million in Q4 2025, from $1.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $1.6 million in Q2 2025 to a low of -$1.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 1.69 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 1.56 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 3.45 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 3.09 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 262,031.00
6 Aldel Financial 397.49 Mn 397.49 Mn - 2.11 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 2.13 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 1.88 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 1.13 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.84 Mn
Sep 30, 2025 1.50 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 768,082.00